Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a …

…, J Peraire, F Vidal, E Leon, À Masabeu, AJ Orti… - The Lancet …, 2021 - thelancet.com
Background Factors affecting outcomes of SARS-CoV-2 infection in people living with HIV
are unclear. We assessed the factors associated with SARS-CoV-2 diagnosis and severe …

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

…, J Vilaró, A Masabeu, AJ Orti… - HIV …, 2019 - Wiley Online Library
Objectives The aim of the study was to assess the rates of discontinuation of integrase
inhibitor regimens because of any neuropsychiatric adverse event (NPAE) and the factors …

Human immunodeficiency virus/hepatits C virus coinfection in Spain: elimination is feasible, but the burden of residual cirrhosis will be significant

…, J Vilaró, E Bernal, S Arponen, AJ Ortí… - Open forum …, 2018 - academic.oup.com
Background We assessed the prevalence of antibodies against hepatitis C virus (HCV-Abs)
and active HCV infection in patients infected with human immunodeficiency virus (HIV) in …

[HTML][HTML] SARS-CoV-2 vaccination coverage and factors associated with low uptake in a cohort of people living with HIV

…, A Imaz, P Suanzes, G Navarro, A Orti… - Microorganisms, 2022 - mdpi.com
People living with HIV (PLWH) are prioritised for SARS-CoV-2 vaccination due to their
vulnerability to severe COVID-19. Therefore, the epidemiological surveillance of vaccination …

Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens

…, JM Llibre, A Imaz, J Peraire, AJ Orti… - Journal of …, 2023 - academic.oup.com
Objectives To assess the clinical and immunovirological outcomes among naive patients with
advanced HIV presentation starting an antiretroviral regimen in real-life settings. Methods …

[PDF][PDF] Transient hypothyroidism after iodine-131 therapy for Grave's disease

N Gómez, JM Gómez Sáez, A Orti… - Journal of Nuclear …, 1995 - Soc Nuclear Med
We studied355 patientswithGrave'sdiseaseto characterize transienthypothyroidismand its
prognosticvaluefollowing1311 therapy. Methods: Thepatientsreceivedtherapeutic1311treat …

Identification of recent HIV-1 infection among newly diagnosed cases in Catalonia, Spain (2006–08)

…, M Navarro, J Vilaró, X Ortín, A Ortí… - … European Journal of …, 2012 - academic.oup.com
Background: Quantification and description of patients recently infected by HIV can provide
an accurate estimate of the dynamics of HIV transmission. Between 2006 and 2008 in …

Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005

…, P Barrufet, MG Sauca, X Ortin, A Ortí… - … y Microbiología Clínica, 2011 - Elsevier
OBJECTIVES: The objectives of this study were to assess the prevalence of transmitted HIV-1
drug resistances (TDR) and HIV-1 subtypes in recently infected patients in Catalonia …

[HTML][HTML] Evolving AIDS-and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998 …

…, L de la Mora, H Knobel, A Orti… - Open forum …, 2024 - academic.oup.com
Background Effective antiretroviral therapy (ART) has substantially reduced acquired
immunodeficiency syndrome (AIDS)-related deaths, shifting the focus to non-AIDS conditions in …

[PDF][PDF] Evaluación pre-post de una actividad preventiva de la infección por VIH dirigida a los adolescentes de las comarcas del sur de Tarragona

…, I Piñas Forcadell, A Ortí Llavería… - … española de salud …, 2003 - SciELO Public Health
Fundamentos: La infección por el virus de la inmunodeficiencia humana (VIH) es uno de los
principales problemas de salud pública que tiene nuestro país. La educación preventiva ha …